CGEM 12.54 (+2.62%)
US2300311063BiotechnologyBiotechnology

Cullinan Oncology (CGEM) Financial Metrics

This table shows a selected set of financial data points of Cullinan Oncology (CGEM). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -3.69 0 -2.76 423.39M -0.29 0 -134.48M -189.9M -153.16M 98.43M
2022 2.46 0 4.28 476.48M 0.22 0 -127.8M -408.83M 111.21M 156.15M
2021 -1.52 0 -10.14 664.68M -0.2 18.94M -43.43M -67.9M -65.57M 59.77M
2020 -1.25 0 0 0 -0.33 0 -29.78M -60.27M -51.8M 168.2M
2019 -1.07 0 0 0 -0.31 0 -20.92M -22.2M -20.66M 63.25M
2018 -1.24 0 0 0 -0.82 0 -13.81M -14.15M -14.19M 33.83M
2016 0 0 0 0 -178.27 0 0 0 -316.7K 91
2015 0 0 0 0 -13.31 0 0 0 -109.51K 118
2014 0 0 0 0 -6.68 0 0 0 -130.54K 2.17K
2013 0 0 0 0 -43.04 0 0 0 -704.66K 2.27K
2012 0 0 0 0 0 0 0 0 0 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.